What types of diseases can this technology help treat?

It is intended for blood purification treatments of intractable diseases such as autoimmune diseases, cardiovascular metabolic diseases, neurodegenerative diseases, and cancer.

How does this differ from conventional fibers?

It allows for precise pore size control up to 1,000nm, which is over 50 times larger than previous technology, enabling the removal of large molecular weight pathogenic substances.

AI News NQ Analysis

Creation of Porous Fiber that Adsorbs Pathogenic Substances of Intractable Diseases

NQ Score 51/100

Key facts

Creation of Porous Fiber that Adsorbs Pathogenic Substances of Intractable Diseases
Toray Industries has developed technology to precisely control the pore size of PMMA porous fibers up to 1,000nm. This allows for the selective adsorption and removal of large molecular weight pathogenic substances, offering a new approach for blood purification treatments for intractable diseases.
Source: article
Date: Thu Mar 26 2026 23:40:51 GMT+0900 (Japan Standard Time)

Direct answer

Toray Industries has developed technology to precisely control the pore size of PMMA porous fibers up to 1,000nm. This allows for the selective adsorption and removal of large molecular weight pathogenic substances, offering a new approach for blood purification treatments for intractable diseases.

Citation: Creation of Porous Fiber that Adsorbs Pathogenic Substances of Intractable Diseases (Thu Mar 26 2026 23:40:51 GMT+0900 (Japan Standard Time)), article
Source: article
Date: Thu Mar 26 2026 23:40:51 GMT+0900 (Japan Standard Time)

AI Summary (NQ-processed)

Toray Industries has developed technology to precisely control the pore size of PMMA porous fibers up to 1,000nm. This allows for the selective adsorption and removal of large molecular weight pathogenic substances, offering a new approach for blood purification treatments for intractable diseases.

AI analysis data is not yet available.

Frequently Asked Questions

Q: What types of diseases can this technology help treat?: A: It is intended for blood purification treatments of intractable diseases such as autoimmune diseases, cardiovascular metabolic diseases, neurodegenerative diseases, and cancer.
Q: How does this differ from conventional fibers?: A: It allows for precise pore size control up to 1,000nm, which is over 50 times larger than previous technology, enabling the removal of large molecular weight pathogenic substances.
Q: What are the key facts in this article?: A: Toray Industries has developed technology to precisely control the pore size of PMMA porous fibers up to 1,000nm. This allows for the selective adsorption and removal of large molecular weight pathogenic substances, offering a new approach for blood purification treatments for intractable diseases.